Acro Biomedical Co., Ltd. Overview
Pro stress-test →Acro Biomedical Co., Ltd. operates as a biotech company offering cordycepin, metallothionein, marine elements, antrodia cinnamomea, and embryonic nutrients. The company is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle.
Strategic Profile
Pro stress-test →The company engages in purchasing products from three suppliers in Taiwan and selling these products in bulk to companies who may use them as ingredients or resell them to their own customers. Operations remain minimal with significant liquidity challenges reflected in extremely low market capitalization and share price.
Competitive Landscape
Pro stress-test →The company operates in the niche nutritional supplement and biotech ingredient space, competing against larger supplement manufacturers and ingredient suppliers such as Nutraceutical International Corporation and various Chinese cordyceps producers. However, ACBM's micro-cap status and minimal operations place it at a significant competitive disadvantage.
Industry Context
Acro Biomedical Co., Ltd. operates in Nutraceutical Ingredients and Supplements.
Key facts
Founded: 2014 · Headquarters: Fishers, Indiana, US · Employees: 1 · Revenue: N/A · Market cap: $42,000